CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Palisade Bio, Inc. - PALI CFD

    0.52
    1.96%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.06
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026151 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026151%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003929 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003929%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 0.51
    Open* 0.5
    1-Year Change* 19.05%
    Day's Range* 0.5 - 0.53
    52 wk Range 0.07-2.86
    Average Volume (10 days) 2.02M
    Average Volume (3 months) 123.43M
    Market Cap 5.83M
    P/E Ratio 0.22
    Shares Outstanding 71.24M
    Revenue N/A
    EPS 0.37
    Dividend (Yield %) N/A
    Beta 1.80
    Next Earnings Date Mar 16, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Sep 25, 2023 0.51 -0.02 -3.77% 0.53 0.53 0.50
    Sep 22, 2023 0.52 -0.03 -5.45% 0.55 0.55 0.52
    Sep 21, 2023 0.55 -0.02 -3.51% 0.57 0.57 0.54
    Sep 20, 2023 0.57 0.00 0.00% 0.57 0.57 0.56
    Sep 19, 2023 0.56 -0.01 -1.75% 0.57 0.58 0.55
    Sep 18, 2023 0.58 -0.01 -1.69% 0.59 0.60 0.57
    Sep 15, 2023 0.59 -0.01 -1.67% 0.60 0.60 0.58
    Sep 14, 2023 0.60 0.00 0.00% 0.60 0.63 0.58
    Sep 13, 2023 0.62 -0.05 -7.46% 0.67 0.67 0.61
    Sep 12, 2023 0.66 -0.03 -4.35% 0.69 0.69 0.61
    Sep 11, 2023 0.70 0.00 0.00% 0.70 0.73 0.68
    Sep 8, 2023 0.73 0.02 2.82% 0.71 0.78 0.68
    Sep 7, 2023 0.76 -0.05 -6.17% 0.81 0.85 0.68
    Sep 6, 2023 1.41 -0.13 -8.44% 1.54 1.90 1.33
    Sep 5, 2023 0.66 0.01 1.54% 0.65 0.66 0.64
    Sep 1, 2023 0.64 0.00 0.00% 0.64 0.65 0.62
    Aug 31, 2023 0.66 0.00 0.00% 0.66 0.66 0.65
    Aug 30, 2023 0.68 0.07 11.48% 0.61 0.69 0.60
    Aug 29, 2023 0.62 0.02 3.33% 0.60 0.63 0.60
    Aug 28, 2023 0.60 0.02 3.45% 0.58 0.60 0.58

    Palisade Bio, Inc. Events

    Time (UTC) Country Event
    Monday, November 13, 2023

    Time (UTC)

    13:30

    Country

    US

    Event

    Q3 2023 Palisade Bio Inc Earnings Release
    Q3 2023 Palisade Bio Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total revenue 0 0.01352 0.01539 0.26 0.26
    Revenue 0.01352 0.01539 0.26 0.26
    Total Operating Expense 42.261 10.6891 8.64709 8.51946 13.5671
    Selling/General/Admin. Expenses, Total 9.307 8.67061 4.58564 4.55927 5.47101
    Research & Development 2.43 2.01845 4.06145 3.96019 8.0961
    Operating Income -42.261 -10.6756 -8.6317 -8.25946 -13.3071
    Interest Income (Expense), Net Non-Operating 20.635 0.02881 0.55795 3.34023 -1.55898
    Other, Net -4.99 -5.62009 -0.27791 -0.00539 -0.79991
    Net Income Before Taxes -26.616 -16.2668 -8.35165 -4.92462 -15.666
    Net Income After Taxes -26.616 -16.2668 -8.35165 -4.92462 -15.666
    Net Income Before Extra. Items -26.616 -16.2668 -8.35165 -4.92462 -15.666
    Net Income -26.616 -16.2668 -8.35165 -4.92462 -15.666
    Income Available to Common Excl. Extra. Items -26.616 -16.2668 -8.35165 -4.92462 -15.666
    Income Available to Common Incl. Extra. Items -26.616 -16.2668 -8.35165 -4.92462 -15.666
    Diluted Net Income -26.616 -16.2668 -8.35165 -4.92462 -15.666
    Diluted Weighted Average Shares 9.30977 2.31155 0.36625 0.12631 0.10887
    Diluted EPS Excluding Extraordinary Items -2.85893 -7.03721 -22.8034 -38.9883 -143.893
    Diluted Normalized EPS 0.41977 -7.03721 -22.8034 -38.9883 -143.893
    Unusual Expense (Income) 30.524
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total revenue 0 0 0 0 0
    Total Operating Expense 3.888 4.027 3.016 32.858 2.36
    Selling/General/Admin. Expenses, Total 2.929 3.227 2.392 2.427 1.261
    Research & Development 0.959 0.8 0.624 0.314 0.692
    Unusual Expense (Income) 0 0 0 30.117 0.407
    Operating Income -3.888 -4.027 -3.016 -32.858 -2.36
    Interest Income (Expense), Net Non-Operating 0.792 5.089 12.738 4.478 -1.67
    Other, Net -1.109 0.011 -1.635 -3.366 0
    Net Income Before Taxes -4.205 1.073 8.087 -31.746 -4.03
    Net Income After Taxes -4.205 1.073 8.087 -31.746 -4.03
    Net Income Before Extra. Items -4.205 1.073 8.087 -31.746 -4.03
    Net Income -4.205 1.073 8.087 -31.746 -4.03
    Income Available to Common Excl. Extra. Items -4.205 1.073 8.087 -31.746 -4.03
    Income Available to Common Incl. Extra. Items -4.205 1.073 8.087 -31.746 -4.03
    Diluted Net Income -4.205 1.073 8.087 -31.746 -4.03
    Diluted Weighted Average Shares 16.2237 13.5328 12.1068 8.9842 7.43177
    Diluted EPS Excluding Extraordinary Items -0.25919 0.07929 0.66797 -3.53354 -0.54227
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.25919 0.07929 0.66797 -0.18132 -0.4875
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 12.374 12.8808 5.64688 6.50839 12.4488
    Cash and Short Term Investments 10.495 10.5292 5.11492 5.78711 11.6749
    Cash & Equivalents 10.495 10.5292 5.11492 5.78711 6.67494
    Short Term Investments 0 5
    Total Receivables, Net 0.15 0.11628 0.02106 0.358 0.37159
    Accounts Receivable - Trade, Net 0 0.11628 0.02106 0.29406 0.3128
    Prepaid Expenses 1.703 1.39979 0.5109 0.36329 0.40227
    Total Assets 12.512 13.0491 6.58389 7.68445 13.8845
    Property/Plant/Equipment, Total - Net 0.112 0.01078 0.04104 0.09031 0.17289
    Property/Plant/Equipment, Total - Gross 0.99145 0.99481
    Accumulated Depreciation, Total -0.95042 -0.82193
    Intangibles, Net 0.14713 0.66894 0.76354 0.88346
    Note Receivable - Long Term 0 0.29824 0.36546
    Other Long Term Assets, Total 0.026 0.01044 0.22704 0.02397 0.01385
    Total Current Liabilities 2.496 3.20593 1.22476 1.05117 1.51457
    Payable/Accrued 0.64935 0.82441 0.83256 0.87507
    Accrued Expenses 1.086 2.32224 0.13569 0 0.41863
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0.087 0
    Other Current Liabilities, Total 0.23434 0.26467 0.2186 0.22088
    Total Liabilities 5.147 3.28123 1.4579 1.6349 5.36933
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt 0
    Other Liabilities, Total 2.651 0.0753 0.23314 0.58373 3.85476
    Total Equity 7.365 9.76792 5.12599 6.04955 8.51513
    Preferred Stock - Non Redeemable, Net 0.002 0.002 0.002 0.01 0.01
    Common Stock 0.143 0.17296 0.03867 0.18205 0.1516
    Additional Paid-In Capital 101.862 247.836 227.067 219.482 217.05
    Retained Earnings (Accumulated Deficit) -94.642 -238.242 -221.976 -213.624 -208.699
    Other Equity, Total -0.00073 -0.00619 -0.00041 0.00263
    Total Liabilities & Shareholders’ Equity 12.512 13.0491 6.58389 7.68445 13.8845
    Total Common Shares Outstanding 14.2392 2.88268 0.64442 0.15171 0.12634
    Total Preferred Shares Outstanding 0.2 0.2 0.2 1 1
    Other Current Assets, Total 0.026 0.83548
    Accounts Payable 1.323
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 8.258 12.374 16.092 14.725 8.7556
    Cash and Short Term Investments 6.644 10.495 14.104 12.653 6.56095
    Cash & Equivalents 6.644 10.495 14.104 12.653 6.56095
    Total Receivables, Net 0.086 0 0 0.059 0.02526
    Accounts Receivable - Trade, Net 0 0 0.059 0.02526
    Prepaid Expenses 1.42 1.879 1.988 2.013 1.30869
    Other Current Assets, Total 0.108 0.8607
    Total Assets 8.35 12.512 16.274 14.949 8.91492
    Property/Plant/Equipment, Total - Net 0.066 0.112 0.156 0.198 0.00724
    Intangibles, Net 0.14164
    Other Long Term Assets, Total 0.026 0.026 0.026 0.026 0.01044
    Total Current Liabilities 1.864 2.496 2.92 3.85 1.01493
    Payable/Accrued 0.52091
    Accrued Expenses 0.717 1.086 0.969 1.303 0.31626
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 0.17776
    Total Liabilities 3.558 5.147 12.354 24.393 1.18613
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 1.694 2.651 9.434 20.543 0.1712
    Total Equity 4.792 7.365 3.92 -9.444 7.72879
    Preferred Stock - Non Redeemable, Net 0.002 0.002 0.002 0.002 0.002
    Common Stock 0.183 0.143 0.13 0.114 0.02883
    Additional Paid-In Capital 103.454 101.862 99.503 94.242 248.228
    Retained Earnings (Accumulated Deficit) -98.847 -94.642 -95.715 -103.802 -240.527
    Other Equity, Total -0.00278
    Total Liabilities & Shareholders’ Equity 8.35 12.512 16.274 14.949 8.91492
    Total Common Shares Outstanding 18.2335 14.2392 12.9299 11.3987 2.88262
    Total Preferred Shares Outstanding 0.2 0.2 0.2 0.2 0.2
    Accounts Payable 1.147 1.323 1.383 1.406
    Current Port. of LT Debt/Capital Leases 0 0.087 0.568 1.141
    Long Term Debt 0 0 0
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Net income/Starting Line -26.616 -16.2668 -8.35165 -4.92462 -15.666
    Cash From Operating Activities -14.773 -9.02513 -7.25568 -7.69242 -13.4162
    Cash From Operating Activities 0.002 0.09227 0.14386 0.1858 0.28921
    Non-Cash Items 16.597 6.19578 0.74383 -2.61672 4.11447
    Cash Taxes Paid 0
    Changes in Working Capital -4.756 0.95364 0.20829 -0.33688 -2.15385
    Cash From Investing Activities -0.054 0 4.99829 -0.09405
    Capital Expenditures 0 -0.00171 -0.09405
    Other Investing Cash Flow Items, Total -0.054 0 5 0
    Cash From Financing Activities 24.609 14.4659 6.58951 1.81423 4.99078
    Financing Cash Flow Items -0.218
    Issuance (Retirement) of Stock, Net 25.01 14.6982 6.55308 1.828 8.73602
    Issuance (Retirement) of Debt, Net -0.183 -0.2323 0.03643 -0.01377 -3.74524
    Foreign Exchange Effects -0.00119 -0.00602 -0.00793 -0.00058
    Net Change in Cash 9.782 5.4396 -0.67219 -0.88783 -8.52001
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -4.205 -26.616 -27.689 -35.776 -2.28508
    Cash From Operating Activities -3.764 -14.773 -11.718 -8.972 -3.94124
    Cash From Operating Activities 0.001 0.002 0.002 0.002 0.00903
    Non-Cash Items 0.72 16.597 21.342 32.167 0.3439
    Changes in Working Capital -0.28 -4.756 -5.373 -5.365 -2.00908
    Cash From Investing Activities 0 -0.054 -0.054 0.294 0
    Other Investing Cash Flow Items, Total 0 -0.054 -0.054 0.294 0
    Cash From Financing Activities -0.087 24.609 25.163 20.618 0
    Issuance (Retirement) of Stock, Net 25.01 25.01 19.801 0
    Issuance (Retirement) of Debt, Net -0.087 -0.183 0.301 0.965 0
    Foreign Exchange Effects -0.00104
    Net Change in Cash -3.851 9.782 13.391 11.94 -3.94228
    Capital Expenditures 0
    Financing Cash Flow Items -0.218 -0.148 -0.148

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Palisade Bio, Inc. Company profile

    About Palisade Bio Inc

    Palisade Bio, Inc, formerly Seneca Biopharma, Inc., is a biopharmaceutical company. The Company is focused on developing therapies that helps patients with acute and chronic gastrointestinal problems from post-operative digestive enzyme damage. Its product candidate, LB1148, is a Phase III-ready protease inhibitor which is developed to reduce abdominal adhesions and help restore bowel function following surgery. It is engaged in developing oral product candidates to treat conditions driven by protease (intestinal digestive enzymes) escaping the intestines, including surgical problems and inflammatory conditions. Its LB1148 is an oral formulation of a serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery.

    Financial summary

    BRIEF: For the nine months ended 30 September 2021, Palisade Bio Inc revenues decreased from $11K to $0K. Net loss increased from $11.8M to $27.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Interest expense increase from $14K to $2.4M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$7.31 to -$3.41.

    Equity composition

    Common Stock $.01 Par, 03/11, 150M auth., 48,366,304 shares issd. Insiders & Strategic holders own 13.61%. IPO:1/07, 16.3M shares @ $1 per Share.

    Industry: Biotechnology & Medical Research (NEC)

    7750 El Camino Real, Suite 5200
    92009

    Income Statement

    • Annual
    • Quarterly

    News

    USD/JPY Climbs Towards Key Highs

    USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.

    11:32, 26 September 2023

    EUR/USD tests key support

    EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

    14:32, 21 September 2023
    Bank of England building

    BoE leaves rates unchanged, GBP drops further as investors look for more clarity

    The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

    11:45, 21 September 2023
    British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

    GBP softer after CPI surprise, JPY focused on any further hints from Ueda

    GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

    12:42, 20 September 2023

    How to Trade The Break & Retest

    In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

    11:59, 20 September 2023

    Cable coils near lows ahead of Fed and BoE rate decisions

    It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

    14:16, 19 September 2023

    FTSE 100 Technical Outlook - 18 September 2023

    In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

    06:55, 19 September 2023

    People also watch

    Oil - Crude

    90.75 Price
    +1.330% 1D Chg, %
    Long position overnight fee 0.0445%
    Short position overnight fee -0.0664%
    Overnight fee time 21:00 (UTC)
    Spread 0.030

    ETH/USD

    1,594.39 Price
    +0.350% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 5.40

    BTC/USD

    26,286.55 Price
    -0.180% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 85.00

    XRP/USD

    0.51 Price
    -0.220% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01192

    Still looking for a broker you can trust?

    Join the 555.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading